 |
|
A Randomized Crossover Study of Silver-Coated Urinary Catheters in Hospitalized Patients
Tobi B. Karchmer, MD, MS;
Eve T. Giannetta, RN;
Carlene A. Muto, MD;
Barbara A. Strain, MA;
Barry M. Farr, MD, MSc
Arch Intern Med. 2000;160:3294-3298.
Background Urinary tract infections (UTIs) account for 30% to 40% of nosocomial infections resulting in morbidity, mortality, and increased length of hospital stay.
Objective To assess the efficacy of a silver-alloy, hydrogel-coated latex urinary catheter for the prevention of nosocomial catheter-associated UTIs.
Methods A 12-month randomized crossover trial compared rates of nosocomial catheter-associated UTI in patients with silver-coated and uncoated catheters. A cost analysis was conducted.
Results There were 343 infections among 27,878 patients (1.23 infections per 100 patients) during 114,368 patient-days (3.00 infections per 1000 patient-days). The relative risk of infection per 1000 patient-days was 0.79 (95% confidence interval, 0.63-0.99; P = .04) for study wards randomized to silver-coated catheters compared with those randomized to uncoated catheters. Infections occurred in 291 of 11,032 catheters used on study units (2.64 infections per 100 catheters). The relative risk of infection per 100 silver-coated catheters used on study wards compared with uncoated catheters was 0.68 (95% confidence interval, 0.54-0.86; P = .001). Fourteen catheter-associated UTIs (4.1%) were complicated by secondary bloodstream infection. One death appeared related to the secondary infection. Estimated hospital cost savings with the use of the silver-coated catheters ranged from $14,456 to $573,293.
Conclusions The risk of infection declined by 21% among study wards randomized to silver-coated catheters and by 32% among patients in whom silver-coated catheters were used on the wards. Use of the more expensive silver-coated catheter appeared to offer cost savings by preventing excess hospital costs from nosocomial UTI associated with catheter use.
From the Departments of Internal Medicine, University of Maryland School of Medicine, Baltimore (Dr Karchmer); University of Virginia Health System, Charlottesville (Mss Giannetta and Strain and Dr Farr); and the University of Pittsburgh, Pittsburgh, Pa (Dr Muto).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis
Jacobsen et al.
Clin. Microbiol. Rev. 2008;21:26-59.
ABSTRACT
| FULL TEXT
Systematic Review: Antimicrobial Urinary Catheters To Prevent Catheter-Associated Urinary Tract Infection in Hospitalized Patients
Johnson et al.
ANN INTERN MED 2006;144:116-126.
ABSTRACT
| FULL TEXT
Infection Control in Intensive Care Units
Mohr et al.
Journal of Pharmacy Practice 2005;18:84-90.
ABSTRACT
A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent
Chaiban et al.
J Antimicrob Chemother 2005;55:51-56.
ABSTRACT
| FULL TEXT
The impact of using silver alloy urinary catheters in reducing the incidence of urinary tract infections in the critical care setting
Madeo et al.
British Journal of Infection Control 2004;5:21-24.
ABSTRACT
Hospital-Onset Infections: A Patient Safety Issue
Gerberding
ANN INTERN MED 2002;137:665-670.
ABSTRACT
| FULL TEXT
Enhancing the Safety of Critically Ill Patients by Reducing Urinary and Central Venous Catheter-related Infections
Saint et al.
Am. J. Respir. Crit. Care Med. 2002;165:1475-1479.
FULL TEXT
Is a Silver Coating a Silver Lining?
Balk
Chest 2002;121:682-683.
FULL TEXT
Silver-Coated Endotracheal Tubes Associated With Reduced Bacterial Burden in the Lungs of Mechanically Ventilated Dogs
Olson et al.
Chest 2002;121:863-870.
ABSTRACT
| FULL TEXT
Other Articles Noted
Evid. Based Nurs. 2001;4:E1-11.
FULL TEXT
Nosocomial Urinary Tract Infections And the Indwelling Catheter : What Is New and What Is True?
Kunin
Chest 2001;120:10-12.
FULL TEXT
|
